Discovery as a Service
StemoniX Discovery as a Service (DaaS) program provides access to our physiologically relevant human induced pluripotent stem cell (iPSC)-based platforms along with scientific experts to design, perform, and analyze your experiments. From cells to assays to data, we leverage expertise in neural and cardiac cell-based toxicology and drug discovery and development studies to generate high quality, consistent results for your custom service needs including assay development and drug screening (efficacy and toxicity)
StemoniX DaaS offers a full range of expertise and capabilities for in vitro functional and phenotypic high-throughput screening. StemoniX can screen our off-the-shelf microBrain and microHeart platforms or create a custom model to suit your needs.
Explore Our Capabilities
Assess compound toxicity at a single point or over time using CellTiter-Glo or LDH-Glo
Learn more about how our custom disease models can be used to bring human biology to the early stages of discovery.